This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "2018-03-14PC DrugAllergySubstance Call Minutes"

From HL7Wiki
Jump to navigation Jump to search
Line 1: Line 1:
 +
R INFORMATION-->
 +
Back to [[Allergy_%26_Intolerance_Drug_Sub-project]]
 +
===Meeting Information===
 +
{|border="1" cellpadding="2" cellspacing="0"
 +
<!---=======================================================================
 +
|                                                                          |
 +
|  MM    MM  TTTTTT  GGGGG        IIIIII  NN    NN  FFFFFF  OOOOO      |
 +
|  MMM  MMM    TT    GG              II    NNN  NN  FF      OO  OO    |
 +
|  MM MMM MM    TT    GG  GGG        II    NN NN NN  FFFF    OO  OO    |
 +
|  MM  M  MM    TT    GG  GG        II    NN  NNN  FF      OO  OO    |
 +
|  MM    MM    TT    GGGGG        IIIIII  NN    NN  FF      OOOOO      |
 +
|                                                                          |
 +
========================================================================--->
 +
| width="50%" colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 Negation Requirements Meeting Minutes''' <br/>
 +
'''Location: Phone'''
 +
| width="50%" colspan="2" align="left" style="background:#f0f0f0;"|'''Date: 2018-03-14'''<br/> '''Time: 5:00-6:00 ET'''
 +
|-
 +
| width="10%" colspan="1" align="right"|'''Facilitator'''
 +
| width="35%" colspan="1" align="left"|Jay Lyle
 +
| width="25%" colspan="1" align="right"|'''Note taker(s)'''
 +
| width="30%" colspan="1" align="left"|Jay Lyle
 +
|-
 +
| border="4" cellpadding="1" colspan="4" style="background:#f0f0f0;"|
 +
|-
 +
| border="1" cellpadding="2" colspan="1" align="left"|'''Attendee'''
 +
| '''Name'''
 +
|colspan="2"|'''Affiliation'''
  
−
* OID (FHIM OID)
+
<!---==============================================================================
−
* Name Common drug substances for allergy and intolerance lists
+
|                                                                                |
−
* Author FHIMS author
+
|    AAAA  TTTTTT  TTTTTT  EEEEEE  NN    NN  DDDDD    EEEEEE  EEEEEE  SSSSS    |
−
* Steward HL7 Terminology
+
|  AA  AA    TT      TT    EE      NNN  NN  DD  DD  EE      EE      SS        |
−
* Clinical Focus Identification of substances administered to patients
+
|  AAAAAA    TT      TT    EEEE    NN NN NN  DD  DD  EEEE    EEEE    SSSS      |
−
* Data element scope Reactant element of allergy or intolerance record
+
|  AA  AA    TT      TT    EE      NN  NNN  DD  DD  EE      EE          SS    |
−
* Inclusion Criteria Specific substances administered to patients in the process of care provision
+
|  AA  AA    TT      TT    EEEEEE  NN    NN  DDDDD    EEEEEE  EEEEEE  SSSSS      |
−
* Exclusion Criteria Substance classes (e.g., sulfa drugs); foods and environmental substances; expressions asserting absence of conditions; Actual conditions caused by exposure (reactions, allergies)
+
|                                                                                |
 +
===============================================================================--->
  
−
* OID
 
−
* Name Common dietary substances for allergy and intolerance lists
 
−
* Author FHIMS author
 
−
* Steward HL7 Terminology
 
−
* Clinical Focus Identification of substances administered to patients
 
−
* Data element scope Reactant element of allergy or intolerance record
 
−
* Inclusion Criteria Foods ingested by patients, both specific (e.g., strawberry) and general (e.g., crustaceans); Substances that may be either foods or drugs (e.g., ethanol)
 
−
* Exclusion Criteria Environmental substances; expressions asserting absence of conditions; Actual conditions caused by exposure (reactions, allergies)
 
  
−
* OID
+
|-
−
* Name Common environmental substances for allergy and intolerance lists
+
| y || Jay Lyle
−
* Author FHIMS author
+
|colspan="2"| JP Systems / VA
−
* Steward HL7 Terminology
+
|-
−
* Clinical Focus Identification of substances to which patients are exposed that may be responsible for allergic or other reactions
+
| y || Russ Leftwich
−
* Data element scope Reactant element of allergy or intolerance record
+
|colspan="2"|
−
* Inclusion Criteria Environmental substances suspected of causing reactions
+
|-
−
* Exclusion Criteria Drugs and foods; expressions asserting absence of conditions; Actual conditions caused by exposure (reactions, allergies)
+
| y || Elaine Ayres
 +
|colspan="2"|
 +
|-
 +
| y || Stephen Chu
 +
|colspan="2"|
 +
|-
 +
| y || George Dixon
 +
|colspan="2"|
 +
|-
 +
| y || Sue Kent
 +
|colspan="2"|
 +
|-
 +
| y|| Lindsey Hoggle
 +
|colspan="2"|
 +
|-
 +
| y || Yanyan Hu
 +
|colspan="2"|
 +
|-
  
−
* OID
+
|colspan="4" style="background:#f0f0f0;"|
−
* Name Common negations of substance causes for allergy and intolerance lists
+
|-
−
* Author FHIMS author
 
−
* Steward HL7 Terminology
 
−
* Clinical Focus Refutation of associations between substances and reactions
 
−
* Data element scope Reactant element of allergy or intolerance record
 
−
* Inclusion Criteria Assertions that a substance or class of substance does not cause adverse reactions in the patient
 
−
* Exclusion Criteria Substances; Actual conditions caused by exposure (reactions, allergies)
 
  
−
* OID
+
 
−
* Name Common substances for allergy and intolerance lists
+
|}
−
* Author FHIMS author
+
<!---=======================================================
−
* Steward HL7 Terminology
+
|                                                          |
−
* Clinical Focus Identification of substances administered to patients
+
|    AAAA    GGGGG  EEEEEE  NN    NN  DDDDD    AAAA      |
−
* Data element scope Reactant element of allergy or intolerance record
+
|  AA  AA  GG      EE      NNN  NN  DD  DD  AA  AA    |
−
* Inclusion Criteria Specific or general substances to which a patient may be exposed and which may be suspected of causing an adverse reaction
+
|  AAAAAA  GG  GGG  EEEE    NN NN NN  DD  DD  AAAAAA    |
−
* Exclusion Criteria Actual conditions caused by exposure (reactions, allergies)
+
|  AA  AA  GG  GG  EE      NN  NNN  DD  DD  AA  AA    |
 +
|  AA  AA  GGGGG  EEEEEE  NN    NN  DDDDD    AA  AA    |
 +
|                                                          |
 +
========================================================--->
 +
 
 +
===Agenda===
 +
'''Agenda Topics''' <br/>
 +
# VSAC text
 +
# Publication of ballot document
 +
# Maintenance; liaison with CCDA & FHIR
 +
 
 +
===Minutes===
 +
<!---================================================================
 +
|                                                                  |
 +
|  MM    MM  IIIIII  NN    NN  UU  UU  TTTTTT  EEEEEE  SSSSS    |
 +
|  MMM  MMM    II    NNN  NN  UU  UU    TT    EE      SS        |
 +
|  MM MMM MM    II    NN NN NN  UU  UU    TT    EEEE    SSSS      |
 +
|  MM  M  MM    II    NN  NNN  UU  UU    TT    EE          SS    |
 +
|  MM    MM  IIIIII  NN    NN  UUUU    TT    EEEEEE  SSSSS      |
 +
|                                                                  |
 +
=================================================================--->
 +
 
 +
'''Minutes/Conclusions Reached:'''<br/>
 +
# We will continue our meetings at the biweekly Wednesday time until the agenda items are resolved.
 +
 
 +
# Re VSAC stewardship: Jay and Elaine to talk to HL7 HTA about appropriate path. This includes maintenance plans.
 +
 
 +
# VSAC text in process. Note [https://www.nlm.nih.gov/vsac/support/authorguidelines/bestpractices.html  guidance] from NLM.
 +
 
 +
# Similar value sets are published by other groups. Check for overlap.
 +
 
 +
# publish in VSAC, using roles (2) and text (3) defined above.
 +
 
 +
# Document publication process steps
 +
## Jay finish applying changes, circulate document
 +
## After VSAC publication publish, include OIDs
 +
 
 +
# FHIR & CCDA adoption
 +
## CCDA: Emma, Lisa
 +
## FHIR: Michelle
 +
 
 +
 
 +
 
 +
 
 +
===Meeting Outcomes===
 +
{|border="1" cellpadding="2" cellspacing="0"
 +
|-
 +
<!---==============================================================
 +
|                                                                |
 +
|    AAAA    CCCCC  TTTTTT  IIIIII  OOOOO  NN    NN  SSSSS    |
 +
|  AA  AA  CC        TT      II    OO  OO  NNN  NN  SS        |
 +
|  AAAAAA  CC        TT      II    OO  OO  NN NN NN  SSSS      |
 +
|  AA  AA  CC        TT      II    OO  OO  NN  NNN      SS    |
 +
|  AA  AA  CCCCC    TT    IIIIII  OOOOO  NN    NN  SSSSS      |
 +
|                                                                |
 +
===============================================================--->
 +
 
 +
| width="100%" align="left" style="background:#f0f0f0;"|'''Actions''' ''
 +
* Please review questions
 +
* Please review ballot outline
 +
 
 +
 
 +
|-
 +
<!---=======================================================================
 +
|                                                                          |
 +
|  NN    NN  EEEEEE  XX  XX  TTTTTT      MM    MM  TTTTTT  GGGGG      |
 +
|  NNN  NN  EE      XX XX    TT        MMM  MMM    TT    GG          |
 +
|  NN NN NN  EEEE      XXX      TT        MM MMM MM    TT    GG  GGG    |
 +
|  NN  NNN  EE      XX XX    TT        MM  M  MM    TT    GG  GG    |
 +
|  NN    NN  EEEEEE  XX  XX    TT        MM    MM    TT    GGGGG      |
 +
|                                                                          |
 +
========================================================================--->
 +
 
 +
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/>
 +
* Review draft list
 +
* Review draft ballot
 +
|}
 +
 
 +
© 2012 Health Level Seven® International.  All rights reserved.

Revision as of 00:15, 15 March 2018

R INFORMATION--> Back to Allergy_&_Intolerance_Drug_Sub-project

Meeting Information

HL7 Negation Requirements Meeting Minutes

Location: Phone

Date: 2018-03-14
Time: 5:00-6:00 ET
Facilitator Jay Lyle Note taker(s) Jay Lyle
Attendee Name Affiliation


y Jay Lyle JP Systems / VA
y Russ Leftwich
y Elaine Ayres
y Stephen Chu
y George Dixon
y Sue Kent
y Lindsey Hoggle
y Yanyan Hu

Agenda

Agenda Topics

  1. VSAC text
  2. Publication of ballot document
  3. Maintenance; liaison with CCDA & FHIR

Minutes

Minutes/Conclusions Reached:

  1. We will continue our meetings at the biweekly Wednesday time until the agenda items are resolved.
  1. Re VSAC stewardship: Jay and Elaine to talk to HL7 HTA about appropriate path. This includes maintenance plans.
  1. VSAC text in process. Note guidance from NLM.
  1. Similar value sets are published by other groups. Check for overlap.
  1. publish in VSAC, using roles (2) and text (3) defined above.
  1. Document publication process steps
    1. Jay finish applying changes, circulate document
    2. After VSAC publication publish, include OIDs
  1. FHIR & CCDA adoption
    1. CCDA: Emma, Lisa
    2. FHIR: Michelle



Meeting Outcomes

Actions
  • Please review questions
  • Please review ballot outline


Next Meeting/Preliminary Agenda Items
  • Review draft list
  • Review draft ballot

© 2012 Health Level Seven® International. All rights reserved.

Retrieved from "https://wiki.hl7.org/w/index.php?title=2018-03-14PC_DrugAllergySubstance_Call_Minutes&oldid=154578"